A patient treated with Augmentin (amoxicillin/clavulanate) for sinus infection still has sinus pressure and green‑yellow nasal discharge after completing therapy; should I switch to levofloxacin or doxycycline?

Treatment Recommendation for Augmentin-Refractory Sinusitis

For a patient with persistent purulent symptoms after completing Augmentin, switch to either levofloxacin or doxycycline—both are guideline-concordant second-line options with equivalent efficacy. 1

Confirming Treatment Failure

Before switching antibiotics, confirm this represents true treatment failure:

• Treatment failure is defined as lack of clinical improvement within 7 days after starting initial antibiotic therapy 1
• Your patient has completed the full Augmentin course and continues with sinus pressure and green-yellow discharge, meeting failure criteria 1
• Reconfirm the diagnosis: persistent purulent nasal drainage with nasal obstruction, facial pain-pressure-fullness, or both 1

Antibiotic Selection for Treatment Failure

The American Academy of Otolaryngology guidelines specifically address your scenario:

For patients initially treated with amoxicillin-clavulanate (Augmentin) who fail therapy, recommended options include: 1

• Doxycycline
• Respiratory fluoroquinolone (levofloxacin or moxifloxacin)
• Clindamycin plus third-generation cephalosporin (cefixime or cefpodoxime)

Why Either Drug Works

Both levofloxacin and doxycycline are equally acceptable choices based on current guidelines 1:

• The 2016 ACP/CDC guidelines list both as appropriate alternatives for acute bacterial rhinosinusitis 1
• Studies show levofloxacin has comparable efficacy to amoxicillin-clavulanate with clinical success rates of 88.4% 2
• Treatment failure often involves bacteria with enhanced resistance to the initial antibiotic, with 49% showing MIC at least 2-fold higher 1

Practical Considerations for Your Decision

Choose levofloxacin if:

• You want once-daily dosing for better compliance 3, 2
• The patient has had gastrointestinal side effects with prior antibiotics (levofloxacin has lower GI adverse event rates at 7.4% vs 21.2% for amoxicillin-clavulanate) 2
• You need broader coverage including Pseudomonas (100% eradication rate for H. influenzae, S. pneumoniae, and S. aureus) 3

Choose doxycycline if:

• Cost is a concern (doxycycline is significantly less expensive)
• You want to reserve fluoroquinolones given stewardship concerns 4, 5
• The patient is younger without risk factors for fluoroquinolone adverse effects 6

Critical Safety Warnings

If prescribing levofloxacin, counsel patients about: 6

• Tendon rupture risk (especially in patients >60 years, on corticosteroids, or transplant recipients)
• Exacerbation of myasthenia gravis (contraindicated if history present)
• Peripheral neuropathy and CNS effects
• Stop immediately if tendon pain, muscle weakness, or hypersensitivity reactions occur

Duration of Therapy

• Prescribe for 5-7 days maximum 4
• Recent data shows 75% of first-line agents and 63% of second-line agents are inappropriately prescribed for >7 days 4
• Guidelines recommend shorter durations to minimize resistance and adverse effects 1

Red Flags Requiring Different Management

Refer or obtain imaging if: 1, 7

• Severe headache, visual changes, proptosis, or periorbital swelling (orbital/intracranial complications)
• Symptoms worsen despite appropriate antibiotic therapy
• Recurrent episodes requiring evaluation for anatomic abnormalities
• Immunocompromised status

Common Pitfall to Avoid

Do not prescribe macrolides (azithromycin, clarithromycin) despite their common use—they account for 25.8% of prescriptions but have high S. pneumoniae resistance rates and are specifically not recommended in current guidelines 1, 5. This represents a major gap between actual practice and evidence-based recommendations 5.